PROSPECTIVE STUDY OF EPSTEIN-BARR VIRUS ANTIBODY TITRES AND SURVIVAL IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA
✍ Scribed by Chan, S.H.; De Thé, G.; Goh, E.H.
- Book ID
- 122563456
- Publisher
- The Lancet
- Year
- 1977
- Tongue
- English
- Weight
- 297 KB
- Volume
- 309
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## RESULTS. In specimens from 107 patients with NPC, EBV was detected by PCR in 2 Department of Pathology, the Johns Hopkins 97 cases (90.7%) and by EBER in situ hybridization in 105 cases (98.1%). In speci-
Serum samples from 154 patients with nasopharyngeal carcinoma (NPC), 374 with other cancers, 1,000 normal controls from Government Employees' Clinic Center (GECC), and 3,642 individuals of various ethnic-dialect groups living in high-risk areas for NPC were collected and the concentration of antibod
A salt-dependent DNA polymerase activity was demonstrated in the culture of an EBV-producing, lymphoblastoid cell line (NPC-204 cells) treated with 5-iodo-2'-deoxyuridine (IUdR). There was a high frequency of levels of antibody to this enzyme in sera of patients with nasopharyngeal carcinoma (NPC).